638 results on '"LEVINE, MARK N."'
Search Results
52. Patient-Reported Outcome Measures in Cancer Care: An Updated Systematic Review and Meta-Analysis.
53. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer
54. Expectant Management Versus Immediate Treatment for Low-Grade Cervical Intraepithelial Neoplasia#: A Randomized Trial in Canada and Brazil
55. Routine Imaging or No Routine Imaging, Is That the Question?
56. Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update
57. The cluster-randomized Quality Initiative in Rectal Cancer trial: evaluating a quality-improvement strategy in surgery
58. External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial
59. Learning Health System for Breast Cancer: Pilot Project Experience
60. Hypofractionated Radiotherapy for Breast Cancer
61. Re: Topoisomerase II Alpha and Responsiveness of Breast Cancer to Adjuvant Chemotherapy
62. Positron Emission Tomography in Staging Early Lung Cancer: A Randomized Trial
63. Adjuvant Chemotherapy for Breast Cancer - 30 Years Later
64. Anthracyclines in Early Breast Cancer
65. The Oncology Nurse Practitioner: A Unique Provider for the Follow-Up for Early-Stage Breast Cancer
66. Incidence, Risk Factors, and Outcomes of Catheter-Related Thrombosis in Adult Patients With Cancer
67. Randomized Trial of Long-Term Follow-Up for Early-Stage Breast Cancer: A Comparison of Family Physician Versus Specialist Care
68. The Importance of Reporting Patient Recruitment Details in Phase III Trials
69. Breast Cancer: Clinical Decision Making
70. Trastuzumab Cardiac Side Effects: Only Time Will Tell
71. Low-Molecular-Weight Heparin Versus Oral Anticoagulant Therapy for the Long-Term Treatment of Symptomatic Venous Thromboembolism: Is There Any Difference in Cancer-Related Mortality?
72. Prophylaxis for Venous Thromboembolism in Cancer Patients With a Central Vein Catheter: New Tones for an Old Song
73. Randomized Trial Comparing Cyclophosphamide, Epirubicin, and Fluorouracil With Cyclophosphamide, Methotrexate, and Fluorouracil in Premenopausal Women With Node-Positive Breast Cancer: Update of National Cancer Institute of Canada Clinical Trials Group Trial MA5
74. Randomized Comparison of Low Molecular Weight Heparin and Coumarin Derivatives on the Survival of Patients With Cancer and Venous Thromboembolism
75. Why Cancer Patients Enter Randomized Clinical Trials: Exploring the Factors That Influence Their Decision
76. Hemorrhagic Complications of Anticoagulant Treatment: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
77. Low Molecular Weight Heparin, Therapy With Dalteparin, and Survival in Advanced Cancer: The Fragmin Advanced Malignancy Outcome Study (FAMOUS)
78. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin
79. Researching the Cost of Research
80. Dalteparin Compared with an Oral Anticoagulant for Thromboprophylaxis in Patients with Cancer
81. Surrogate Outcomes in Quality-of-Life Research: Where Will We End Up?: In Reply
82. neu/erbB-2 Overexpression and Response to Hormonal Therapy in Premenopausal Women in the Adjuvant Breast Cancer Setting: Will It Play in Peoria? Part II
83. Do Quality-of-Life Randomized Clinical Trials Support Clinicians in Their Decision-Making?
84. Beyond the Development of Quality-of-Life Instruments: Where Do We Go From Here?
85. A randomized controlled trial comparing the frequency of acute reactions to plasma-removed platelets and prestorage WBC-reduced platelets
86. Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer
87. Anthracycline Adjuvant Chemotherapy: How Much Is Enough?
88. Hemorrhagic Complications of Anticoagulant Treatment
89. Treatment of Venous Thrombosis in the Cancer Patient
90. Epidemiology of Thrombosis in Cancer
91. Clinical Utility of a Rapid Whole-Blood d-Dimer Assay in Patients with Cancer Who Present with Suspected Acute Deep Venous Thrombosis
92. The Thrombophilic State Induced by Therapeutic Agents in the Cancer Patient
93. Treatment of Venous Thromboembolism in Cancer Patients
94. Hemorrhagic Complications of Anticoagulant Treatment
95. The Quality Initiative in Rectal Cancer (QIRC) trial: study protocol of a cluster randomized controlled trial in surgery
96. Ardeparin (Low-Molecular-Weight Heparin) vs Graduated Compression Stockings for the Prevention of Venous Thromboembolism: A Randomized Trial in Patients Undergoing Knee Surgery
97. The supportive care needs of newly diagnosed cancer patients attending a regional cancer center
98. Hemorrhagic Complications of Thrombolytic Therapy in the Treatment of Myocardial Infarction and Venous Thromboembolism
99. Prevention of Venous Thromboembolism
100. Hemorrhagic Complications of Anticoagulant Treatment
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.